Back to User profile » Dr Xingsheng Hu
Paper published by Dr Xingsheng Hu:
Original Research
Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial
Hu XS, Han XH, Yang S, Li N, Wang L, Song YY, Mu H, Shi YK
Cancer Management and Research 2019, 11:4449-4459
Published Date: 13 May 2019